EMONO

DRUG5 trials

Sponsors

Air Liquide Santé International, University Hospital, Bordeaux, University Hospital, Tours, Centre Hospitalier Universitaire de Nīmes

Conditions

AnxietyDepressionLate-Life DepressionLow Back PainNeuralgiaNeurocognitive DisordersResistant Depression, TreatmentSickle Cell Crisis

Phase 2

EMONO for the Treatment of Peripheral Neuropathic Pain

CompletedNCT02957851

Air Liquide Santé InternationalNeuralgia

Start: 2016-11-30End: 2018-08-31Updated: 2018-09-21

Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-

Not yet recruitingNCT06382389

University Hospital, ToursDepression, Neurocognitive Disorders

Start: 2026-09-01End: 2028-09-01Target: 96Updated: 2026-06-17

Phase 3

Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

TerminatedNCT04076748

University Hospital, BordeauxSickle Cell Crisis

Start: 2021-07-20End: 2024-07-21Updated: 2026-06-22

Unknown Phase

Nitrous Oxide for Late-Life Depression - PROTO-BRAIN

CompletedNCT05007028

University Hospital, ToursLate-Life Depression, Resistant Depression, Treatment

Start: 2021-11-16End: 2024-12-19Updated: 2025-11-24

Efficacy on Anxiety of the Digital Music Application Versus Equimolar Mixture of Oxygen and Nitrous Oxide in Patients Receiving CT-guided Lumbar Infiltration

RecruitingNCT06928740

Centre Hospitalier Universitaire de NīmesAnxiety, Low Back Pain

Start: 2025-10-21End: 2029-06-01Target: 128Updated: 2026-02-20